NCT00324506View on ClinicalTrials.gov

Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Multiple Sclerosis
Interventions
DRUG

Mycophenolate Mofetil (CellCept)

Trial Locations (3)

14203

Buffalo Neuroimaging Analysis Center (BNAC), Buffalo

48334

Michigan Institute for Neurological Disorders (M.I.N.D.), Farmington Hills

75390

University of Texas Southwestern Medical Center at Dallas, Dallas

Sponsors

Collaborators (1)

Aspreva Pharmaceuticals
All Listed Sponsors
collaborator

Aspreva Pharmaceuticals

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER